Название: Gastroenterological Endoscopy
Автор: Группа авторов
Издательство: Ingram
Жанр: Медицина
isbn: 9783131470133
isbn:
[31] Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001; 96(2):417–423
[32] Ismail S, Kylänpää L, Mustonen H, et al. Risk factors for complications of ERCP in primary sclerosing cholangitis. Endoscopy. 2012; 44(12):1133–1138
[33] Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998; 48(1):1–10
[34] Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology. 1976; 70(3):314–320
[35] Sauter G, Grabein B, Huber G. et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy. 1990; 22(4):164–167
[36] Niederau C, Pohlmann U, Lübke H, Thomas L. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc. 1994; 40(5):533–537
[37] Brand M, Bizos D, O’Farrell P, Jr. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev. 2010(10):CD007345
[38] Motte S, Deviere J, Dumonceau JM. et al. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991; 101(5):1374–1381
[39] De Palma GD, Galloro G, Siciliano S. et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001; 53(6):547–553
[40] Bangarulingam SY, Gossard AA, Petersen BT. et al. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol. 2009; 104(4):855–860
[41] Byl B, Devière J, Struelens MJ, et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study. Clin Infect Dis. 1995; 20(5):1236–1240
[42] Saxena P, Singh VK, Lennon AM. et al. Endoscopic management of acute cholecystitis after metal stent placement in patients with malignant biliary obstruction: a case series. Gastrointest Endosc. 2013; 78(1):175–178
[43] Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011; 74(2):321–327.e1, 3
[44] Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol. 2013; 11(1):27–37.e1
[45] Isayama H, Kawabe T, Nakai Y, et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol. 2006; 4(9):1148–1153
[46] Williams DB, Sahai AV, Aabakken L, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut. 1999; 44(5):720–726
[47] Eloubeidi MA, Tamhane A, Varadarajulu S, Wilcox CM. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc. 2006; 63(4):622–629
[48] Guarner-Argente C, Shah P, Buchner A. et al. Use of antimicrobials for EUS-guided FNA of pancreatic cysts: a retrospective, comparative analysis. Gastrointest Endosc. 2011; 74(1):81–86
[49] Diehl DL, Cheruvattath R, Facktor MA, Go BD. Infection after endoscopic ultrasound-guided aspiration of mediastinal cysts. Interact Cardiovasc Thorac Surg. 2010; 10(2):338–340
[50] Annema JT, Veseliç M, Versteegh MI, Rabe KF. Mediastinitis caused by EUS-FNA of a bronchogenic cyst. Endoscopy. 2003; 35(9):791–793
[51] Khashab MA, Dewitt J. EUS-guided biliary drainage: is it ready for prime time? Yes! Gastrointest Endosc. 2013; 78(1):102–105
[52] Khashab MA, Fujii LL, Baron TH, et al. EUS-guided biliary drainage for patients with malignant biliary obstruction with an indwelling duodenal stent (with videos). Gastrointest Endosc. 2012; 76(1):209–213
[53] Khashab MA, Kim KJ, Tryggestad EJ, et al. Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy. Gastrointest Endosc. 2012; 76(5):962–971
[54] Shah JN, Marson F, Weilert F, et al. Single-operator, single-session EUS-guided anterograde cholangiopancreatography in failed ERCP or inaccessible papilla. Gastrointest Endosc. 2012; 75(1):56–64
[55] Khashab MA, Valeshabad AK, Modayil R, et al. EUS-guided biliary drainage by using a standardized approach for malignant biliary obstruction: rendezvous versus direct transluminal techniques (with videos). Gastrointest Endosc. 2013; 78(5):734–741
[56] Khashab MA, Varadarajulu S. Endoscopic ultrasonography as a therapeutic modality. Curr Opin Gastroenterol. 2012; 28(5):467–476
[57] Lipp A, Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database Syst Rev. 2006(4):CD005571
[58] Jain NK, Larson DE, Schroeder KW, et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med. 1987; 107(6):824–828
[59] Maple JT, Petersen BT, Baron TH. et al. Direct percutaneous endoscopic jejunostomy: outcomes in 307 consecutive attempts. Am J Gastroenterol. 2005; 100(12):2681–2688
[60] Maple JT. Direct percutaneous endoscopic jejunostomy in the obese: proceed with caution. Gastrointest Endosc. 2008; 67(2):270–272
[61] Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther. 2011; 34(5):509–518
[62] Fernández J, Ruiz del Arbol L, Gómez C, et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006; 131(4):1049–1056, quiz 1285
[63] Baddour LM, Epstein AE, Erickson CC, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young. Council on Cardiovascular Surgery and Anesthesia. Council on Cardiovascular Nursing. Council on Clinical Cardiology. Interdisciplinary Council on Quality of Care and Outcomes Research. A summary of the update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. J Am Dent Assoc. 2011; 142(2):159–165
[64] Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004; 351(16):1645–1654
[65] Piraino B, Bernardini J, Brown E, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int. 2011; 31(6):614–630
[66] Yip T, Tse KC, Lam MF, et al. Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int. 2007; СКАЧАТЬ